Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
EARLY_PHASE1
This is a pilot vaccine study in adults with either WHO grade II astrocytom...
Status
Completed
Location
Comprehensive Cancer Center of Wake Forest University